Genentech, Inc. et al v. Sanofi-Aventis Deutschland GMBH et al

Filing 232

BRIEFING ORDER. Signed by Magistrate Judge Bernard Zimmerman on 12/18/2009. (bzsec, COURT STAFF) (Filed on 12/18/2009)

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 v. SANOFI-AVENTIS DEUTSCHLAND GMBH, et al., Defendant(s). GENENTECH, INC., et al., Plaintiff(s), ) ) ) ) ) ) ) ) ) ) ) UNITED STATES DISTRICT COURT NORTHERN DISTRICT OF CALIFORNIA

No. C08-4909 SI (BZ) BRIEFING ORDER

Following a telephone conference about the current dispute over defendant Sanofi's "Experimental Test Report," at which all parties were represented by counsel, IT IS ORDERED as follows: 1. Sanofi has leave to file a motion for an appropriate If it fails to do so in a fashion which

protective order.

Genentech deems timely, Genentech has leave to file a motion to compel. In either event, the burden of establishing

whether the Report is entitled to protection under Rule 26 lies with Sanofi. (N.D. Cal. 2005). 2. The moving papers shall be signed by the most senior 1 Contratto v. Ethicon, Inc., 227 F.R.D. 304,

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

attorney representing the moving party.

The Court will deem

that attorney's signature as certifying that the attorney has read the moving papers and that they are consistent with Federal Rules of Civil Procedure 1 and 26, especially 26(c). 3. The opposition shall be signed by the most senior The Court will deem that

attorney representing that party.

attorney's signature as certifying that the attorney has read the opposition and that it is consistent with Federal Rules of Civil Procedure 1 and 26, especially 26(c). Dated: December 18, 2009 Bernard Zimmerman United States Magistrate Judge
G:\BZALL\-REFS\GENENTECH\DISC ORD 7.wpd

2